SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-014154
Filing Date
2019-01-23
Accepted
2019-01-22 18:10:35
Documents
1
Group Members
FHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.JAMES TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A (AMENDMENT NO. 1) d693596dsc13da.htm SC 13D/A 115116
  Complete submission text file 0001193125-19-014154.txt   116979
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88896 | Film No.: 19536192
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A